Duchenne Muscular Dystrophy Treatment Market Accelerates as Gene Therapies and Exon-Skipping Breakthroughs Offer New Hope to Pediatric Patients
Duchenne Muscular Dystrophy (DMD) has long been one of the most challenging genetic disorders to treat, primarily affecting young boys and leading to progressive muscle degeneration. However, the therapeutic landscape has changed dramatically over the last few years. We have moved from a focus on symptomatic management—primarily using corticosteroids—to sophisticated molecular...
0 Commentarii 0 Distribuiri 18 Views 0 previzualizare